JNJ · News · 20260915N
Portfolio Reshaping (M&A / Divestiture)
JOHNSON & JOHNSON · 2026-09-15 · Importance 58 · Surprise 42 · In source text
Apollo Global Management is reportedly in talks to acquire Johnson & Johnson’s DePuy Synthes orthopedics business for nearly $20 billion. A transaction would accelerate J&J’s shift toward higher-growth businesses and could provide substantial upfront cash while streamlining its portfolio. The reported deal also carries valuation, litigation-exposure, and execution risks and could reduce J&J’s participation in future orthopedics upside.
Key facts
- Apollo Global Management is reportedly in talks to acquire Johnson & Johnson's DePuy Synthes orthopedics business for nearly $20 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| assets | positive | contingent | +1.5% | Apollo Global Management is reportedly in talks to acquire Johnson & Johnson's DePuy Synthes orthopedics business for nearly $20 billion. |
| revenue | negative | contingent | — | Apollo Global Management is reportedly in talks to acquire Johnson & Johnson's DePuy Synthes orthopedics business for nearly $20 billion. |